Structural approaches to pathway-specific antimicrobial agents.

Area of Science:

• Microbiology
• Drug Discovery
• Medicinal Chemistry

Background:

• Antibiotic discovery has historically relied on phenotypic screening.
• A shift towards structure-based drug design (SBDD) intensified efforts.
• Current challenges necessitate more advanced discovery paradigms.

Purpose of the Study:

• To provide a perspective on the historical evolution of antibiotic discovery strategies.
• To highlight the transition towards holistic and host-relevant approaches in modern antibiotic development.
• To outline key strategies employed in contemporary antibiotic research.

Main Methods:

• Review of historical antibiotic discovery methodologies.
• Analysis of the evolution from phenotypic to structure-based design.
• Examination of current holistic approaches incorporating host-mimicking conditions.
• Discussion of target identification, deconvolution, and SBDD refinement.

Main Results:

• The field has progressed from empirical screening to rational design.
• Modern antibiotic discovery integrates multiple strategies for enhanced efficacy.
• Assay conditions are increasingly optimized to mimic the host environment.

Conclusions:

• A holistic approach, integrating phenotypic and structure-based methods with host-relevant conditions, is crucial for future antibiotic discovery.
• Target identification and validation within the whole cell are key advancements.
• Continued refinement of structure-based design remains important.